Amy Wu, MD
Otolaryngology · New York, NYNPI 1033355052
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,819 of the $5,149 with a category attached, or 74.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 17.7%. Reporting peaked in 2022 at $2,339 and has fallen 68.4% since, to $740 in 2025.
Across 146 payments — averaging $35.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$911
- Regeneron Healthcare Solutions, Inc.$718
- Acclarent, Inc$679
- Optinose US, Inc.$657
- Sanofi$594
- Olympus America Inc.$458
- plus $1K from 19 others
Across 2 payments — averaging $2628.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$5K
What the payments were for
- Travel & lodging$81016%
- Food & beverage$3,81974%
- Education$621%
- Other$4589%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 8 | $911 |
| Regeneron Healthcare Solutions, Inc. | 29 | $718 |
| Acclarent, Inc | 12 | $679 |
| Optinose US, Inc. | 30 | $657 |
| Sanofi | 25 | $594 |
| Olympus America Inc. | 1 | $458 |
| GSK | 11 | $212 |
| AstraZeneca(2 entities) | 2 | $156 |
| Neurent Medical Limited | 1 | $125 |
| Kaleo, Inc. | 5 | $111 |
| Integra Lifesciences Corporation | 3 | $95 |
| Alk-abello, Inc | 4 | $68 |
| Blue Earth Diagnostics | 1 | $62 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Stryker | 1 | $36 |
| Acelrx Pharmaceuticals, Inc. | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Medtronic | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Aerin Medical Inc. | 1 | $17 |
| USWM, LLC | 1 | $14 |
| Intersect ENT, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acclarent Aera$136
- ULTOMIRIS$130
- NEUROMARK System$125
- NEUROMARK Radiofrequency Console$125
- RELIEVA SPINPLUS Balloon Sinuplasty System$122
- RELIEVA SCOUT Multi-Sinus Dilation System$122
- TruDi$122
- Xhance$105
How this compares
$5,149 in reported general payments places this provider in the 80th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 398 | $4,133 |
| Epinephrine | 15 | $4,092 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 36 | $3,987 |
| Mometasone Furoate | 36 | $3,301 |
| Fluocinolone Acetonide Oil | 46 | $1,999 |
| Azelastine Hcl | 47 | $1,088 |
| Famotidine | 82 | $775 |
| Ofloxacin | 11 | $652 |
| Triamcinolone Acetonide | 15 | $423 |
| Omeprazole | 55 | $387 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $275 |
| Acetic Acid | 11 | $156 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New York
- Roheen RaithathaNew York$830K
- Dennis KrausNew York$159K
- Anthony DelsignoreNew York$89K
- Satish GovindarajNew York$39K
- Lawrence LustigNew York$33K
- Justin GolubNew York$30K
- Brett MilesNew York$30K
- David HiltzikNew York$25K
- Milan AminNew York$23K
- Ashutosh KackerNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.